Toni Lange1,2, Andres Luque Ramos3, Katinka Albrecht4, Klaus-Peter Günther2, Hannes Jacobs3, Jochen Schmitt1, Falk Hoffmann3, Jens Goronzy2, Anne Postler5. 1. Zentrum für Evidenzbasierte Gesundheitsversorgung, Universitätsklinikum und Medizinische Fakultät Carl Gustav Carus, TU Dresden, Dresden, Deutschland. 2. UniversitätsCentrum für Orthopädie und Unfallchirurgie, Universitätsklinikum Carl Gustav Carus, TU Dresden, Dresden, Deutschland. 3. Department für Versorgungsforschung, Carl von Ossietzky Universität Oldenburg, Oldenburg, Deutschland. 4. Programmbereich Epidemiologie, Deutsches Rheumaforschungszentrum Berlin, Berlin, Deutschland. 5. UniversitätsCentrum für Orthopädie und Unfallchirurgie, Universitätsklinikum Carl Gustav Carus, TU Dresden, Dresden, Deutschland. Anne.Postler@uniklinikum-dresden.de.
Abstract
BACKGROUND: Osteoarthritis of the hip or knee joint is a widespread disease with a strong influence on the quality of life. At present, the extent of conservative treatment with physical therapies and analgesics before the use of a total joint arthroplasty (TJA) of the hip or knee is largely unclear in Germany. OBJECTIVES: The aim was to analyze the prescription frequency according to regional and socio-demographic factors. MATERIALS AND METHODS: Based on routine health care data from BARMER insurance, patients who received a TJA of the hip or knee from 2011 to 2013 were analyzed. Included were consistently insured patients with the main discharge diagnosis of osteoarthritis who did not receive any further TJA for eight quarters before and after replacement. The prescription frequency of physical therapies and analgesics, stratified according to age groups, gender, number of comorbidities and federal state was analyzed. RESULTS: 40,242 persons with hip TJA and 35,652 persons with knee TJA were included. In the year prior to surgery, 49.4% of patients (hip TJA: 49.9%; knee TJA: 48.9%) received at least one physical therapy and 81.0% were prescribed analgesics. Regionally, the prescription frequency of physical therapies for hip TJA varied between 35.7% (Bremen) and 70.6% (Saxony) and for knee TJA between 37.6% (Saarland) and 66.9% (Saxony). CONCLUSION: The prescription frequency of physical therapy does not fully correspond to current treatment recommendations. The prescription of physical therapies in the year before the TEP shows regional differences, with fundamentally lower prescription frequencies in the former states of West Germany.
BACKGROUND:Osteoarthritis of the hip or knee joint is a widespread disease with a strong influence on the quality of life. At present, the extent of conservative treatment with physical therapies and analgesics before the use of a total joint arthroplasty (TJA) of the hip or knee is largely unclear in Germany. OBJECTIVES: The aim was to analyze the prescription frequency according to regional and socio-demographic factors. MATERIALS AND METHODS: Based on routine health care data from BARMER insurance, patients who received a TJA of the hip or knee from 2011 to 2013 were analyzed. Included were consistently insured patients with the main discharge diagnosis of osteoarthritis who did not receive any further TJA for eight quarters before and after replacement. The prescription frequency of physical therapies and analgesics, stratified according to age groups, gender, number of comorbidities and federal state was analyzed. RESULTS: 40,242 persons with hip TJA and 35,652 persons with knee TJA were included. In the year prior to surgery, 49.4% of patients (hip TJA: 49.9%; knee TJA: 48.9%) received at least one physical therapy and 81.0% were prescribed analgesics. Regionally, the prescription frequency of physical therapies for hip TJA varied between 35.7% (Bremen) and 70.6% (Saxony) and for knee TJA between 37.6% (Saarland) and 66.9% (Saxony). CONCLUSION: The prescription frequency of physical therapy does not fully correspond to current treatment recommendations. The prescription of physical therapies in the year before the TEP shows regional differences, with fundamentally lower prescription frequencies in the former states of West Germany.
Entities:
Keywords:
Analgesic drugs; Conservative treatment; Demography; Osteoarthritis; Total joint replacement
Authors: T Schäfer; R Pritzkuleit; C Jeszenszky; J Malzahn; W Maier; K P Günther; F Niethard Journal: Osteoarthritis Cartilage Date: 2012-12-05 Impact factor: 6.576
Authors: Marita Cross; Emma Smith; Damian Hoy; Sandra Nolte; Ilana Ackerman; Marlene Fransen; Lisa Bridgett; Sean Williams; Francis Guillemin; Catherine L Hill; Laura L Laslett; Graeme Jones; Flavia Cicuttini; Richard Osborne; Theo Vos; Rachelle Buchbinder; Anthony Woolf; Lyn March Journal: Ann Rheum Dis Date: 2014-02-19 Impact factor: 19.103
Authors: E Swart; E M Bitzer; H Gothe; M Harling; F Hoffmann; D Horenkamp-Sonntag; B Maier; S March; T Petzold; R Röhrig; A Rommel; T Schink; C Wagner; S Wobbe; J Schmitt Journal: Gesundheitswesen Date: 2016-06-28
Authors: Amanda E Nelson; Kelli D Allen; Yvonne M Golightly; Adam P Goode; Joanne M Jordan Journal: Semin Arthritis Rheum Date: 2013-12-04 Impact factor: 5.532
Authors: T E McAlindon; R R Bannuru; M C Sullivan; N K Arden; F Berenbaum; S M Bierma-Zeinstra; G A Hawker; Y Henrotin; D J Hunter; H Kawaguchi; K Kwoh; S Lohmander; F Rannou; E M Roos; M Underwood Journal: Osteoarthritis Cartilage Date: 2014-01-24 Impact factor: 6.576
Authors: J H Abbott; M C Robertson; C Chapple; D Pinto; A A Wright; S Leon de la Barra; G D Baxter; J-C Theis; A J Campbell Journal: Osteoarthritis Cartilage Date: 2013-01-08 Impact factor: 6.576
Authors: Laure Gossec; Gillian Hawker; Aileen M Davis; Jean Francis Maillefert; L Stefan Lohmander; Roy Altman; Jolanda Cibere; Philip G Conaghan; Marc C Hochberg; Joanne M Jordan; Jeffrey N Katz; Lyn March; Nizar Mahomed; Karel Pavelka; Ewa M Roos; Maria E Suarez-Almazor; Gustavo Zanoli; Maxime Dougados Journal: J Rheumatol Date: 2007-06 Impact factor: 4.666
Authors: Jason A Sharpe; Brook I Martin; Julie M Fritz; Michael G Newman; John Magel; Megan E Vanneman; Anne Thackeray Journal: Fam Pract Date: 2021-06-17 Impact factor: 2.267